Advanced CKD was linked to a higher likelihood of both fatal and non-fatal adverse outcomes after acute myocardial infarction treatment. Patients with advanced chronic kidney disease (ACKD) with acute ...

AstraZeneca has made the decision to end the CAPItello-280 trial evaluating capivasertib in patients with metastatic castration-resistant prostate cancer.

No association seen for incontinence with MVPA classification, but link seen with type 2 diabetes, dyslipidemia, stroke.

Addition of revascularization to optimized medical therapy not beneficial in patients with carotid stenosis ≥50 percent and low or intermediate predicted stroke risk.

Now, as the new commissioner of the U.S. Food and Drug Administration (FDA), he's wasting no time charting a new course for the agency.

An investigator presented 90-day safety results from the first human trial of a proprietary water-soluble hydrogel injected into the vas deferens for non-permanent contraception.

The combination of toripalimab, nimotuzumab, and chemotherapy has shown promise as neoadjuvant treatment for patients with high-risk, locally advanced penile cancer, according to researchers.

Radiation from CT scans may cause as many as 5% of cancers diagnosed each year in the United States, research suggests.

Some benefits include mitigation of cardiac toxicity, peripheral neuropathy, cognitive impairment, and dyspnea.

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

An estimated 40 to 63 percent of sudden cardiac arrest cases could be prevented by improving unfavorable profiles.

Lorundrostat, a selective aldosterone synthase inhibitor, significantly reduced 24-hour systolic blood pressure in individuals with uncontrolled and treatment-resistant hypertension, according to ...